This is a routine dividend reinvestment disclosure with no trading signal. Monitor upcoming quarterly earnings and any pipeline updates for material catalysts.
Price Chart
Executive Summary
GSK filed a routine 6-K reporting the acquisition of ADSs by multiple PDMRs (directors and officers) through dividend reinvestment following the July 9, 2026 dividend payment. Transactions occurred on July 10 and July 14, 2026, at prices between $51.67 and $52.74, with total aggregate value of approximately $82,000. This is a standard administrative disclosure with no material financial or strategic implications.
Key Facts
- Nine PDMRs acquired ADSs via dividend reinvestment on July 10 and July 14, 2026
- Prices ranged from $51.6696 to $52.7353 per ADS
- Total shares acquired: approximately 2,036 ADSs
- Total transaction value: approximately $82,000
- Dividend paid to shareholders on July 9, 2026
Financial Impact
Approximately $82,000 in aggregate ADS acquisitions via dividend reinvestment — immaterial relative to GSK's $104B market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (GSK) — Batch item 1 | 0001654954-26-006691 |
| Document: 0001654954-26-006691-index-headers.html | 0001654954-26-006691 |
| Document: 0001654954-26-006691-index.html | 0001654954-26-006691 |
| Document: 0001654954-26-006691.txt | 0001654954-26-006691 |
| 6-K Filing (GSK) — Batch item 5 | 0001654954-26-006691 |
| Document: 0001654954-26-006691-index-headers.html | 0001654954-26-006691 |
| Document: 0001654954-26-006691-index.html | 0001654954-26-006691 |
| Document: 0001654954-26-006691.txt | 0001654954-26-006691 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access